MOESM2 of Testing the 2018 NIA-AA research framework in a retrospective large cohort of patients with cognitive impairment: from biological biomarkers to clinical syndromes

Additional file 2. a) Column plot representing the 3 cerebrospinal fluid (CSF) biomarkers profiles in amyloid-PET positive (n = 37) and amyloid-PET negative (n = 7) subjects (n tot = 44). b) Column plot representing the percentage of amyloid-PET positive and amyloid-PET negative subjects in AD-conti...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Carandini, Tiziana, Arighi, Andrea, Sacchi, Luca, Fumagalli, Giorgio, Pietroboni, Anna, Ghezzi, Laura, Colombi, Annalisa, Scarioni, Marta, Fenoglio, Chiara, Riz, Milena, Marotta, Giorgio, Scarpini, Elio, Galimberti, Daniela
Format:	Bild
Sprache:	eng
Schlagworte:	Cell Biology Chemical Sciences not elsewhere classified Computational Biology FOS: Chemical sciences FOS: Clinical medicine FOS: Health sciences Immunology Medicine Mental Health Neuroscience
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Additional file 2. a) Column plot representing the 3 cerebrospinal fluid (CSF) biomarkers profiles in amyloid-PET positive (n = 37) and amyloid-PET negative (n = 7) subjects (n tot = 44). b) Column plot representing the percentage of amyloid-PET positive and amyloid-PET negative subjects in AD-continuum (n = 35), non-AD (n = 6), and Normal (n = 3) profiles, as assessed by CSF analyses.
DOI:	10.6084/m9.figshare.9987026